Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted ...

The National Comprehensive Cancer Network (NCCN) policy summit, “Primary Care and Oncology Collaboration to Improve Patient ...

The panelists began by explaining why close coordination is so important.

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...

Early cancer detection through advanced imaging remains a cornerstone of breast cancer care. Identifying high-risk patients is crucial for implementing personalized screening protocols that can ...

Research led by Professors Jianxing He and Wenhua Liang from the First Affiliated Hospital of Guangzhou Medical University ...

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Cancer apps can provide patients with helpful tools, but there are risks associated with these apps, according to experts.

The researchers analyzed data on 1412 patients with primary CSCC. According to NCCN guidelines, 64 patients were low risk, 842 were high risk, and 506 were very high risk. According to the 40-GEP ...